Cargando…
Bispecific Monoclonal Antibodies in Multiple Myeloma: Data from ASH 2022: A Podcast
The introduction of novel immunotherapies has transformed the treatment landscape in multiple myeloma (MM). The addition of these agents has significantly improved patient outcomes; however, MM remains largely incurable, with heavily pretreated patients suffering from shorter survival times. To addr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329949/ https://www.ncbi.nlm.nih.gov/pubmed/37328635 http://dx.doi.org/10.1007/s12325-023-02551-9 |